Tuesday, September 23, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Safran Stock: Soars to Record High on Strong Earnings

Robert Sasse by Robert Sasse
July 31, 2025
in Stocks
0
Safran Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

French aerospace giant Safran has outperformed expectations with a stellar first-half performance, reporting a 27% surge in operating profit to €2.5 billion and a 13% revenue increase to €14.8 billion. Investors responded enthusiastically, driving shares up nearly 5% to a record €294.50, pushing its market value to €125 billion. The stock has already gained 40% this year, cementing its position as a top performer in the CAC 40 and EuroStoxx 50 indices. Key to this success are the high-demand Leap engines, co-produced with GE Aerospace, which power Airbus and Boeing jets. Despite supply chain bottlenecks delaying aircraft deliveries, Safran plans to boost Leap engine output by 15–20% this year.

Upgraded Forecasts and Expansion Plans

Buoyed by robust demand, Safran raised its full-year guidance, projecting adjusted operating profit between €5.0–5.1 billion, up from €4.8–4.9 billion, and mid-teens revenue growth. The company is also eyeing strategic partnerships, including a defense collaboration with a Canadian rival, to diversify its portfolio. Meanwhile, a potential €400 million investment in a carbon-brake factory underscores confidence in long-term growth. Despite geopolitical tensions over potential U.S. tariffs, Safran’s diversified supply chain positions it to navigate challenges seamlessly.

Ad

Safran Stock: Buy or Sell?! New Safran Analysis from September 23 delivers the answer:

The latest Safran figures speak for themselves: Urgent action needed for Safran investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 23.

Safran: Buy or sell? Read more here...

Tags: Safran
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Quantum Computing Stock
Stocks

Quantum Computing Stock Dips Despite Major Contract Wins

September 16, 2025
Coinbase Stock
Stocks

Institutional Partnership Fuels Optimism for Coinbase’s Future

September 16, 2025
Strategy Stock
Stocks

MicroStrategy’s Bitcoin Bet Faces Market Skepticism

September 16, 2025
Next Post
GEA Stock

GEA Stock: Upgraded Forecast Signals Strong Growth

S&P Global Stock

S&P Global Stock: Mixed Signals Amid Leadership Shift

Lufthansa Stock

Lufthansa Stock: Multiple Challenges Threaten Growth Outlook

Recommended

Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago
Footwear Industry Markets and money (1)

Anne Mehlman Appointed as EVP and President of Crocs Brand Search Underway for New CFO

2 years ago
Moog Stock

Security Breach at Defense Contractor Moog Highlights Sector Vulnerabilities

4 weeks ago

Malibu Boats Remains Optimistic Despite Decline in Earnings

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Can Pacific Biosciences’ New Screening Strategy Reverse Its Fortunes?

Opendoor Shares Face Reality Check as Influencer Support Shifts

Ziff Davis: Insider Confidence Clashes with Cautious Analyst Outlook

Main Capital Shares Face Pressure Despite Dividend Boost

Halozyme’s Patent Battle with Merck: A Potential Billion-Dollar Inflection Point

Seacoast Banking of Florida: A Regional Powerhouse Gaining Momentum

Trending

Unitedhealth Stock
Analysis

UnitedHealth Navigates Mounting Cost Pressures After Volatile Year

by Robert Sasse
September 23, 2025
0

UnitedHealth Group is working to regain its footing following a challenging period. The managed care giant's stock,...

BigBear.ai Stock

BigBear.ai Stock: Low Valuation Masks Deeper Fundamental Concerns

September 23, 2025
Coherus BioSciences Stock

Coherus BioSciences: A High-Stakes Pivot to Oncology

September 23, 2025
Pacific Biosciences Stock

Can Pacific Biosciences’ New Screening Strategy Reverse Its Fortunes?

September 23, 2025
Opendoor Stock

Opendoor Shares Face Reality Check as Influencer Support Shifts

September 23, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • UnitedHealth Navigates Mounting Cost Pressures After Volatile Year
  • BigBear.ai Stock: Low Valuation Masks Deeper Fundamental Concerns
  • Coherus BioSciences: A High-Stakes Pivot to Oncology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com